Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2014

View Archived Issues

Brazilian researchers characterize novel small-molecule inhibitors of inflammatory cytokines

Lanreotide autogel improves symptoms of diarrhea and QoL

Novel topical formulation of alpha-LACE for the treatment of presbyopia

Cortistatin derivative shows potential in experimental CNV

Alcobra to initiate phase IIb study of metadoxine in Fragile X syndrome

Pharmacokinetic data presented for novel cyclic boronic acid beta-lactamase inhibitor

Nuvilex and University of Northern Colorado to research cannabinoids for cancer

U.S. investigators patent novel steroids acting on GABA(A) receptors

AMAGINE-1 study of brodalumab in moderate to severe plaque psoriasis meets endpoints

ReNeuron presents promising phase I data for the CTX0E03 cell therapy in stroke patients

Tripeptide KdPT evaluated in proof-of-concept ulcerative colitis trial

Takeda reviews highlights of fourth quarter of fiscal 2013

AC Immune and Piramal Imaging form agreement for Tau protein diagnostics

Novavax reports follow-up data from phase I RSV F-protein vaccine trial

Abeona Therapeutics' therapies obtain orphan drug designation for Sanfilippo syndrome

Lilly reports positive phase III results for insulin peglispro

Results from phase IIb studies of MedImmune's mavrilimumab and sifalimumab

Idenix Pharmaceuticals reports discovery of dinucleotide compounds for HCV

Janssen Pharmaceutica discloses new ROR-gamma modulators

Novel C9orf72 mRNA expression modulators disclosed by Isis Pharmaceuticals

Tesaro reports positive data from phase III trial of rolapitant

Santhera's phase III study of idebenone for DMD meets primary endpoint

GSK's darapladib misses primary endpoint in acute coronary syndrome trial

Shire acquires Lumena Pharmaceuticals and two new therapeutic compounds

AstraZeneca announces phase III results for saxagliptin/dapagliflozin combination

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...